Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Boehringer Ingelheim
Moodys
Merck
McKesson

Last Updated: November 12, 2019

DrugPatentWatch Database Preview

LISINOPRIL AND HYDROCHLOROTHIAZIDE Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Lisinopril And Hydrochlorothiazide patents expire, and what generic alternatives are available?

Lisinopril And Hydrochlorothiazide is a drug marketed by Apotex Inc, Aurobindo, Heritage Pharma, Hikma Intl Pharms, Invagen Pharms, Lupin, Mylan, Prinston Inc, Sandoz, Sun Pharm Inds Ltd, Teva, and Watson Labs. and is included in thirteen NDAs.

The generic ingredient in LISINOPRIL AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; lisinopril. There are thirty-two drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; lisinopril profile page.

Summary for LISINOPRIL AND HYDROCHLOROTHIAZIDE
Drug patent expirations by year for LISINOPRIL AND HYDROCHLOROTHIAZIDE
Recent Clinical Trials for LISINOPRIL AND HYDROCHLOROTHIAZIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
IPCA Laboratories Ltd.Phase 1
Scripps Translational Science InstituteN/A
William Beaumont HospitalsPhase 4

See all LISINOPRIL AND HYDROCHLOROTHIAZIDE clinical trials

Pharmacology for LISINOPRIL AND HYDROCHLOROTHIAZIDE
Synonyms for LISINOPRIL AND HYDROCHLOROTHIAZIDE
151063-30-8
DTXSID50164702
Hydrochlorothiazide / Lisinopril
Hydrochlorothiazide mixt. Lisinopril
Hydrochlorothiazide mixture with Lisinopril
hydrochlorothiazide, lisinopril drug combination
L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, (S)-, mixt. with 6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide (1:1)
L-Proline, N2-((1S)-1-carboxy-3-phenylpropyl)-L-lysyl-, mixt. with 6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide (1:1)
Lisinopril / HCTZ
Lisinopril / hydrochlorothiazide
Lisinopril HCTZ mixt
Lisinopril mixture with hydrochlorothiazide
Lisinopril-HCTZ mixt.
Lisinopril-hydrochlorothiazide
Lisinopril-hydrochlorothiazide mixt.
SCHEMBL2521283
Zestoretic

US Patents and Regulatory Information for LISINOPRIL AND HYDROCHLOROTHIAZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Ltd LISINOPRIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 076007-002 Jul 1, 2002 AB RX No No   Start Trial   Start Trial   Start Trial
Sandoz LISINOPRIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 076262-002 Jul 1, 2002 AB RX No No   Start Trial   Start Trial   Start Trial
Sun Pharm Inds Ltd LISINOPRIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 076007-003 Jul 1, 2002 AB RX No No   Start Trial   Start Trial   Start Trial
Sandoz LISINOPRIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 075926-003 Jul 1, 2002 DISCN No No   Start Trial   Start Trial   Start Trial
Apotex Inc LISINOPRIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 076674-001 Oct 5, 2004 DISCN No No   Start Trial   Start Trial   Start Trial
Lupin LISINOPRIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; lisinopril TABLET;ORAL 077912-003 Sep 27, 2006 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Express Scripts
Moodys
Baxter
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.